Curis Inc

CRISNASDAQ • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
0.32 USD
↗ 0.12 (55.98%)AT CLOSE (11:59 AM EDT)
0.31
↘ 0.02 (4.67%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
0.31
↘ 0.02 (4.67%)
🔴Market: CLOSED

Shares of Curis Inc (CRIS) are trading at $0.32. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 26, 2026.

Open?$0.21
High?$0.38
Low?$0.21
Prev. Close?$0.21
Volume?109.8M
Avg. Volume?4.2M
VWAP?$0.32
Rel. Volume?25.98x
Bid / Ask
Bid?$0.27 × 100
Ask?$0.36 × 100
Spread?$0.09
Midpoint?$0.31
Valuation & Ratios
Market Cap?12.5M
Shares Out?39.0M
Float?12.7M
Float %?92.2%
P/E Ratio?N/A
P/B Ratio?0.98
EPS?-$0.54
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Clinical-Stage Platforms
Employees
24
Market Cap
12.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.curis.com
Listed
2000-08-01
Address
128 SPRING STREET
LEXINGTON, MA 02421
Phone: 617-503-6500
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
92
Short Sent.?
75
Piotroski F-Score?0/9Weak
Altman Z-Score?-60.01Distress
Confidence?40%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.07%Low
Short Interest?261.9K
Days to Cover?1.4
Free Float12.7M
Avg Daily Volume187.2K
Settlement Date2026-06-15
Financial Health
Current Ratio?1.11Adequate
Quick Ratio?1.11Adequate
Cash Ratio?1.00Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.98CHEAP▾
P/S?
Peers
100
S&P
72
1.77CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.4CHEAP▾
EV/Sales?
S&P
97
-0.36CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-166.6%WEAK▾
ROA?
S&P
3
-71.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-2527818
Fundamentals ratios updated end of day
MarketsMoversWatchlist